Amarin Corp Plc (AMRN)

[Biobillionair]

Raf--

"We believe Improve-It showed that ezetimibe in combination with a statin offers a significant benefit to high-risk patients with coronary heart disease," he said."

I think Merck will get a reduction of CVE in diabetics label. Study also heightened doubts about LDL being an approval biomarker...

The FDA approved injectables solely based on lower is better theory...this may in fact double the hemorrhagic stroke risk. Vessel rupture instead of blockage.

Thanks for posting.

BB